Insight Molecular Diagnostics (IMDX) Construction in Progress (2019 - 2026)
Insight Molecular Diagnostics (IMDX) posted Construction in Progress of $471000.0 for Q1 2026, down 38.43% sequentially from $765000.0 in Q4 2025, and up 30.83% YoY from $360000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Construction in Progress (2019 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 8 years of Construction in Progress data on file, last reported at $471000.0 in Q1 2026.
- Quarterly Construction in Progress rose 30.83% year-over-year to $471000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $471000.0 (up 30.83% YoY) and the FY2025 annual result came in at $765000.0, up 125.0% from the prior year.
- Construction in Progress retreated to $471000.0 in Q1 2026 per IMDX's latest filing, from $765000.0 in the prior quarter.
- The five-year high for Construction in Progress was $3.1 million in Q1 2022, with the low at $263000.0 in Q2 2025.
- Average Construction in Progress over 5 years is $997117.6, with a median of $685000.0 recorded in 2025.
- Year-over-year, Construction in Progress surged 730.52% in 2022 and sank 81.87% in 2023.
- Insight Molecular Diagnostics' Construction in Progress stood at $2.1 million in 2022, then plunged by 66.07% to $726000.0 in 2023, then sank by 53.17% to $340000.0 in 2024, then jumped by 125.0% to $765000.0 in 2025, then tumbled by 38.43% to $471000.0 in 2026.
- Business Quant data shows IMDX's Construction in Progress at $471000.0 in Q1 2026, $765000.0 in Q4 2025, and $685000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 471,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 471,000.00 |
| Dec 31, 2025 | 765,000.00 |
| Sep 30, 2025 | 685,000.00 |
| Jun 30, 2025 | 263,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Dec 31, 2024 | 340,000.00 |
| Sep 30, 2024 | 302,000.00 |
| Jun 30, 2024 | 359,000.00 |
| Mar 31, 2024 | 323,000.00 |
| Dec 31, 2023 | 726,000.00 |
| Sep 30, 2023 | 708,000.00 |
| Jun 30, 2023 | 518,000.00 |
| Mar 31, 2023 | 726,000.00 |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | 2.86 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 285,000.00 |
| Jun 30, 2021 | 344,000.00 |